Aiming to evaluate the utility of blood-based and other biomarkers for Alzheimer's disease diagnosis and managementJoint research to enhance dementia…
Daily call abandonment fell 56% and average wait times dropped 58% after Hyro's AI agents were introduced to optimize patient…
Seven posters to be presented, including new X-TOLE OLE data supporting the ability to attain and regain extended periods of…
Following the positive opinions of the Committee for Medicinal Products for Human Use (CHMP), the European Commission has granted marketing…
BURLINGTON, Mass. and JERUSALEM, Nov. 25, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),…
Company to host a webcast today at 8:30 a.m. Eastern Time NEW YORK, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Anavex…
First publicly listed company to actively investigate psilocybin’s potential impact on longevity NEW YORK, Nov. 25, 2025 (GLOBE NEWSWIRE) --…
Cambridge, Mass., Nov. 24, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for…
The collaboration aims to support care coordination and enhance patient safety at AdventHealth. NEW YORK, Nov. 20, 2025 /PRNewswire/ --…
SAN DIEGO, Nov. 20, 2025 /PRNewswire/ -- Aspen Neuroscience, Inc., a clinical-stage biotechnology company pioneering autologous regenerative therapies, today announced the…